Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases
  4. AI-Pathway Companion Prostate Cancer from Siemens Healthineers approved for use in Europe as medical device
Press release

AI-Pathway Companion Prostate Cancer from Siemens Healthineers approved for use in Europe as medical device

Published on March 3, 2020

The AI-Pathway Companion from Siemens Healthineers uses Artificial Intelligence, including Natural Language Processing, to bring together data on a patient’s disease and treatment status and presents it via an intuitive graphical user interface.
Copyright: Siemens Healthineers

Download this press release(pdf, 156.80 KB)
1

Depending on available input data

2

AI-Pathway Companion Prostate Cancer VA10A supports prostate cancer adenocarcinoma cases only. The product is not yet commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact the local Siemens Healthineers organization for further details.

3Source: Rawla, P., Epidemiology of Prostate Cancer, World J Oncol. 2019 Apr; 10(2): 63–89, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497009/
4

Feature supported by AI-Pathway Companion Connector.

5

AI-Pathway Companion Prostate Cancer VA10A supports NCCN and EAU guidelines.

6https://uroweb.org/guideline/prostate-cancer/
7https://www.nccn.org/professionals/physician_gls/default.aspx
8

Prerequisite for automatic patientspecific mapping: All data is available as required per guideline.

9

Prof. Seifert is employed by an institution that receives financial support from Siemens Healthineers for collaborations.

10

Dr. Christian Wetterauer is employed by an institution that receives financial support from Siemens Healthineers for collaborations.

Siemens Healthineers 2020

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalising healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion.